FLAG CHEMOTHERAPY

Clinical trials for FLAG CHEMOTHERAPY explained in plain language.

Never miss a new study

Get alerted when new FLAG CHEMOTHERAPY trials appear

Sign up with your email to follow new studies for FLAG CHEMOTHERAPY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New hope for leukemia patients who have run out of options

Disease control Not yet recruiting

This early-stage study aims to find safe doses of two new drugs, lisaftoclax and pelcitoclax, when combined with a standard chemotherapy called FLAG. It is for adults whose T-cell acute lymphoblastic leukemia (T-ALL) has come back or hasn't responded to previous treatments. The m…

Matched conditions: FLAG CHEMOTHERAPY

Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control

Last updated Mar 18, 2026 14:41 UTC

FLAG CHEMOTHERAPY

Get alerted when new FLAG CHEMOTHERAPY trials appear

New hope for leukemia patients who have run out of options